Top

Reactions Weekly

Published in:

01-05-2023 | Melanoma | Case report

Nivolumab

Squamous cell carcinoma and keratoacanthoma: 4 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Poole M, et al. To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma. Archives of Dermatological Research 315 : 903-915, No. 4, Jan 2023. Available from: URL: http://doi.org/10.1007/s00403-022-02468-3

Title: Nivolumab
Squamous cell carcinoma and keratoacanthoma: 4 case reports
Publication date: 01-05-2023
Publisher: Springer International Publishing
Keywords: Melanoma
Melanoma
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38544-1

2024 ASCO Annual Meeting

Springer Medicine

Nivolumab

Squamous cell carcinoma and keratoacanthoma: 4 case reports

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Qingdai-compound

Buprenorphine

Oxytocin/vasopressin

Nivolumab

Posaconazole

Risedronic-acid